[{"address1": "2450 Holcombe Blvd.", "address2": "Suite X", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "(713) 913-5608", "website": "https://www.salariuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Salarius Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is based in Houston, Texas.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mark J. Rosenblum CPA", "age": 71, "title": "Acting CEO, Executive VP of Finance & CFO", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 339050, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.56, "open": 4.62, "dayLow": 4.24, "dayHigh": 4.62, "regularMarketPreviousClose": 4.56, "regularMarketOpen": 4.62, "regularMarketDayLow": 4.24, "regularMarketDayHigh": 4.62, "payoutRatio": 0.0, "beta": 0.501, "forwardPE": -0.47110143, "volume": 90961, "regularMarketVolume": 90961, "averageVolume": 257328, "averageVolume10days": 529140, "averageDailyVolume10Day": 529140, "bid": 4.24, "ask": 4.41, "bidSize": 1, "askSize": 1, "marketCap": 2201657, "fiftyTwoWeekLow": 4.23, "fiftyTwoWeekHigh": 108.0, "fiftyDayAverage": 7.5304, "twoHundredDayAverage": 15.595675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -648092, "profitMargins": 0.0, "floatShares": 33932, "sharesOutstanding": 509643, "sharesShort": 123799, "sharesShortPriorMonth": 53573, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.24290001, "heldPercentInsiders": 0.0047400002, "heldPercentInstitutions": 0.025139999, "shortRatio": 0.29, "shortPercentOfFloat": 0.2433, "impliedSharesOutstanding": 509643, "bookValue": -0.39, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -5103412, "trailingEps": -23.7, "forwardEps": -9.17, "lastSplitFactor": "1:15", "lastSplitDate": 1755475200, "enterpriseToEbitda": 0.114, "52WeekChange": -0.82439023, "SandP52WeekChange": 0.1653893, "quoteType": "EQUITY", "currentPrice": 4.32, "recommendationKey": "none", "totalCash": 794886, "totalCashPerShare": 23.393, "ebitda": -5675021, "totalDebt": 0, "quickRatio": 0.358, "currentRatio": 0.612, "returnOnAssets": -1.43519, "returnOnEquity": -6.60367, "freeCashflow": -2657078, "operatingCashflow": -4143201, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Salarius Pharmaceuticals, Inc.", "marketState": "CLOSED", "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -23.7, "epsForward": -9.17, "fiftyDayAverageChange": -3.2103996, "fiftyDayAverageChangePercent": -0.42632526, "twoHundredDayAverageChange": -11.275675, "twoHundredDayAverageChangePercent": -0.7230001, "priceToBook": -11.076924, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1422541800000, "postMarketChangePercent": -0.925925, "postMarketPrice": 4.28, "postMarketChange": -0.04, "regularMarketChange": -0.24, "corporateActions": [], "postMarketTime": 1758321613, "regularMarketTime": 1758312002, "exchange": "NCM", "messageBoardId": "finmb_330031056", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -5.26315, "regularMarketPrice": 4.32, "regularMarketDayRange": "4.24 - 4.62", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 257328, "fiftyTwoWeekLowChange": 0.09000015, "fiftyTwoWeekLowChangePercent": 0.021276632, "fiftyTwoWeekRange": "4.23 - 108.0", "fiftyTwoWeekHighChange": -103.68, "fiftyTwoWeekHighChangePercent": -0.96, "fiftyTwoWeekChangePercent": -82.439026, "dividendDate": 1563753600, "shortName": "Salarius Pharmaceuticals, Inc.", "displayName": "Salarius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-20"}]